Alkermes (ALKS) FCF Margin (2010 - 2026)

Alkermes' (ALKS) quarterly FCF Margin came in at 43.22% in Q1 2026, down 7216.0% year-on-year from 0.61% in Q1 2025, and down 197.72% on a QoQ basis from 44.23% in Q4 2025.

Alkermes (ALKS) FCF Margin (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has 17 years of FCF Margin data on file, last reported at 43.22% in Q1 2026.

  • On a quarterly basis, FCF Margin fell 7216.0% year-over-year to 43.22% in Q1 2026; TTM through Mar 2026 was 14.2%, a 1762.0% decrease from a year earlier, with the FY2025 full-year figure at 32.55%, up 650.0% from the prior year.
  • FCF Margin for Q1 2026 stood at 43.22%, down from 44.23% in the prior quarter.
  • Over the last five years, FCF Margin for ALKS reached as high as 44.23% in Q4 2025 and fell as low as 383.38% in Q2 2022.
  • Historically, FCF Margin has averaged 25.47% across 5 years, with a median of 21.4% in 2025.
  • Across the five-year window, FCF Margin slumped 39210 bps in 2022 and surged 41674 bps in 2023, its largest moves.
  • Year by year, FCF Margin stood at 2.95% in 2022, then surged by 911 bps to 23.9% in 2023, then surged by 76 bps to 42.01% in 2024, then increased by 5 bps to 44.23% in 2025, then tumbled by 198 bps to 43.22% in 2026.
  • Per Business Quant data, the three most recent FCF Margin figures were 43.22% in Q1 2026, 44.23% in Q4 2025, and 21.4% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -5.22%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 12.86%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -5.35%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 46.54%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 9.93%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 17.73%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -2.77%
10 Alkermes 9.72 Bn 9.21 Bn 331.33 Mn -43.22%

Historic Data

Download Data
DateValue
Mar 31, 2026 -43.22%
Dec 31, 2025 44.23%
Sep 30, 2025 21.40%
Jun 30, 2025 35.12%
Mar 31, 2025 28.94%
Dec 31, 2024 42.01%
Sep 30, 2024 19.39%
Jun 30, 2024 34.81%
Mar 31, 2024 3.64%
Dec 31, 2023 23.90%
Sep 30, 2023 22.38%
Jun 30, 2023 33.37%
Mar 31, 2023 -9.79%
Dec 31, 2022 -2.95%
Sep 30, 2022 -307.78%
Jun 30, 2022 -383.38%
Mar 31, 2022 4.99%
Dec 31, 2021 6.89%
Sep 30, 2021 26.51%
Jun 30, 2021 8.73%